This federal contract award, valued at $1,371.74, was issued by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business. The contract is for the delivery of AIRSUPRA 90-80 MCG INHALER 10.7GM, a pharmaceutical product, and has an ultimate completion date of December 31, 2024.
Dakota Drug, Inc. is a key supplier of pharmaceutical products, medical supplies, and healthcare equipment to the U.S. government, particularly the Department of Defense. The company holds a significant single-award Indefinite Delivery Contract (IDC) with the DLA, identified as SPE2DB24D8001, valued at $999,999,999.00, which allows it to provide a comprehensive range of medical items to support U.S. Armed Forces medical operations. This latest contract award is a delivery order under that larger IDC vehicle.
The contract is a firm fixed-price, delivery order with no set-aside designation, indicating Dakota Drug, Inc.'s competitive standing in the federal marketplace.
Generated 3/31/25, 9:36 AM